Roswell Park Team Exploring Promising Biomarker for Tracking Breast Cancer Response to CDK4/6 Therapy
January 28, 2026
January 28, 2026
BUFFALO, New York, Jan. 28 [Category: BizHospital] -- The Roswell Park Comprehensive Cancer Center posted the following news release:
* * *
Roswell Park Team Exploring Promising Biomarker for Tracking Breast Cancer Response to CDK4/6 Therapy
*
BUFFALO, N.Y. -Many patients with a common form of advanced breast cancer experience good responses when they're treated with targeted drugs known as CDK4/6 inhibitors in addition to endocrine (hormo . . .
* * *
Roswell Park Team Exploring Promising Biomarker for Tracking Breast Cancer Response to CDK4/6 Therapy
*
BUFFALO, N.Y. -Many patients with a common form of advanced breast cancer experience good responses when they're treated with targeted drugs known as CDK4/6 inhibitors in addition to endocrine (hormo . . .